TCR-T technology is a T cell immunotherapy technique that engineers patient’s autologous T cells to express tumor antigen-specific T cell receptors (TCRs).
TCR-T technology is a T cell immunotherapy technique that engineers patient’s autologous T cells to express tumor antigen-specific T cell receptors (TCRs). TCR-T therapy includes the identification of tumor-specific TCRs, the construction of TCR expression vectors, TCR-T cell manufacturing, and immune monitoring after TCR-T transfusion.
EN
EN
